Evidence map›Paper›PMID 26801762›Full record

ArticleBMC research notes2016

Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.

Rasa Ruseckaite, Kerri Beckmann, Michael O'Callaghan, David Roder, Kim Moretti, John Zalcberg, Jeremy Millar, Sue Evans

Abstract read
In one paragraph

Article in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rasa RuseckaiteDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. rasa.ruseckaite@monash.edu.
Kerri BeckmannCentre for Population Health, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia. kerri.beckmann@unisa.edu.au.
Michael O'CallaghanSouth Australian Prostate Cancer Clinical Outcomes Collaborative, Department of Urology, Repatriation General Hospital, Adelaide, SA, Australia. michael.ocallaghan2@sa.gov.au.
David RoderCentre for Population Health, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia. david.roder@unisa.edu.au.
Kim MorettiCentre for Population Health, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia. kim@theurologist.net.au.
John ZalcbergDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. john.zalcberg@monash.edu.
Jeremy MillarWilliam Buckland Radiation Oncology Department, the Alfred, Melbourne, VIC, Australia. jeremy.millar@monash.edu.
Sue EvansDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. sue.evans@monash.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer is the most commonly diagnosed and prevalent malignancy reported to Australian cancer registries, with numerous studies from single institutions summarizing patient outcomes at individual hospitals or States. In order to provide an overview of patterns of care of men with prostate cancer across multiple institutions in Australia, a specialized dataset was developed. This dataset, containing amalgamated data from South Australian and Victorian prostate cancer registries, is called the South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset (SA-VIC PCHORD).

resultsA total of 13,598 de-identified records of men with prostate cancer diagnosed and consented between 2008 and 2013 in South Australia and Victoria were merged into the SA-VIC PCHORD. SA-VIC PCHORD contains detailed information about socio-demographic, diagnostic and treatment characteristics of patients with prostate cancer in South Australia and Victoria. Data from individual registries are available to researchers and can be accessed under individual data access policies in each State.

conclusionsThe SA-VIC PCHORD will be used for numerous studies summarizing trends in diagnostic characteristics, survival and patterns of care in men with prostate cancer in Victoria and South Australia. It is expected that in the future the SA-VIC PCHORD will become a principal component of the recently developed bi-national Australian and New Zealand Prostate Cancer Outcomes Registry to collect and report patterns of care and standardised patient reported outcome measures of men nation-wide in Australia and New Zealand.

Indexed as

RegistriesAdultAgedAged, 80 and overAntineoplastic AgentsDatasets as TopicDisease ManagementGamma RaysHumansInformation Storage and RetrievalMaleMiddle AgedProstatic NeoplasmsSocioeconomic FactorsSouth AustraliaSurvival AnalysisAntineoplastic Agents

Identifiers

PMID26801762
PMCPMC4724115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.